Radiodermatitis Market Set to Surge Owing to Expanding Radiotherapy Use Radiodermatitis, skin damage caused by radiation therapy, is treated with corticosteroids, barrier creams, dressings, and biologics aimed at accelerating healing and reducing inflammation. These products offer benefits like targeted relief, reduced infection risk, and improved comfort. The growing global cancer prevalence has increased the need for effective radiodermatitis management, spurring research into advanced dressings and treatments. The market includes both over-the-counter and prescription-grade solutions, with a focus on biomaterials and growth factors offering superior outcomes. Get More Insights on Radiodermatitis Market https://www.patreon.com/posts/radiodermatitis-129424566 #RadiodermatitisMarket #RadiationTherapySkinCare #RadioprotectiveDressings #OncologySupportiveCare #CoherentMarketInsights